Susan Hasty, Publisher
Table of Contents . . . February 22nd, 1999Non-Subscriber - Summaries Only
Conference Coverage (Retrovirus) - "Self Vaccination" Via Intermittent Drug Therapy?
Conference Coverage (Retrovirus) - CD8+ T Cells Crucial For HIV Control
Conference Coverage (Retrovirus) - Drug-Resistant HIV Hides From Tests
Conference Coverage (Retrovirus) - Inner-City Patients Not Taking HAART
Conference Coverage (Retrovirus) - T-Cell Memory Seen As Key to HIV Disease, AIDS Vaccine
Conference Coverage (Retrovirus) - Variable AIDS Progression Linked to MHC Gene Differences
Outbreaks (TB) - Prison Outbreaks Reach Community
Pathogenesis (Kaposi's sarcoma) - IFN-gamma Triggers Tat Effects
Proteomics - Viral Killing Strategy Examined
Testing (TB) - Value of DTH Skin Testing Limited in HIV+ Kids
Therapy (TB) - Rifampin Monoresistance Usually Seen in HIV+
AIDS Therapies (Crixivan) - Higher Blood Levels of Crixivan Achieved with Twice-Daily Regimen
Disease Associations (HIV/HPV) - Protease Inhibitor Use Associated with Rise in Oral Warts Incidence
Drug Resistance - HIV Gets Tougher as Resistance Grows
Drug Resistance (Crixivan) - Viral Rebound Not Associated with Resistance
Education and Prevention - China Urges AIDS Education for Migrant Population
HIV Vaccines - Arizona Residents Take Part in Large-Scale Vaccine Test
HIV Vaccines - U.S. Firm Begins Test of Vaccine in Thailand
HIV Vaccines (ALVAC vCP205) - NIAID Opens First Vaccine Trial in Africa
Pathogenesis (HIV) - Finding May Explain HIV's Ability To Infect Cells Lacking Key Target
Prisons - TB Outbreak in California Prison
Transmission - Saliva Kills HIV Infected Cells and Disables Virus
Disease Associations - "Histological Damage of Hepatitis C Virus in HIV Infected Patients: A Case Control Study."
Blood Donation (HIV-1 Epidemiology) - "HIV-1 Subtypes Among Blood Donors from Rio de Janeiro, Brazil."
Infectious Disease Surveillance - "European Surveillance of Infectious Diseases: The Case of AIDS and Tuberculosis."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.